INTRODUCTION
A number of eucaryotic cell proteins of high biological relevance lack the signal sequences that usually guide protein translocation across the ER membrane and are secreted by routes other than the endoplasmic reticulum/Golgi (ER/G) pathway. They include basic fibroblast growth factor (bFGF) and acidic fibroblast growth factor (aFGF), cytokines (interleukin 1 [IL-1]), hormones ((34-thymosin and prothymosin), coagulation factors (the a-chain of factor XIII), differentiation factors (the muscle lectin [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , and membrane structural proteins (amphoterin) (1, 2) . 756 Molecular Medicine, Volume 2, Number 6, November 1996 Several mechanisms have been proposed to explain the export of these proteins across cell membranes. These mechanisms include the fusion of cytosolic vesicles with the cell membrane, transient disruption of the cell membrane permeability (3), the direct translocation of cytosolic polypeptides across the cell membrane, the concentration of peptides in cellular ectoplasm beneath regions of the plasma membrane which evaginate to form labile extracellular vesicles, and the existence of selective plasma membrane pores for protein transport. Among the latter are some ATPases of a superfamily of ATP-driven transport proteins which includes the multiple drug-resistant (MDR) protein and the cystic fibrosis conductance regulator, known as the cystic fibrosis transmembrane rectifier (CFTR) (1) .
The terminal components of the complement system (C5b-9) form the membrane attack complex (MAC) pore. The MAC pore is a hollow amphipatic cylinder of effective internal radius of 5-7 nm layered with hydrophilic domains on the outside and hydrophobic domains in the interior. The deposition of the terminal complement components and the formation of the MAC pore can be triggered either by the immune or the nonimmune activation of the complement cascade (4, 5) .
MAC insertion into the cell plasma membrane may have lytic or nonlytic outcomes depending on several factors, which include the number and size of the pores, the kinetics of opening and closing of the pores, the efficacy of the cell volume regulatory mechanisms in balancing the net cation gain through the pore, and the ability of the cell to shed MAC pore-enriched membranes. In turn, the number and size of the MAC pores inserted in a given cell are restricted by a family of complement regulatory proteins such as the decay-accelerating factor (DAF) and CD59 (6) (7) (8) . Some of these complement regulatory proteins are species specific and only restrict MAC pore formation in their own species, a phenomenon known as homologous restriction (9 (13) . The observation that homologous MAC insertion induces the release of bFGF is particularly interesting, because this peptide lacks signal sequence and plays a crucial role in mammalian physiology and pathology. Mechanistically, the release of growth factors from MAC-impacted cells could be either secondary to the activation of cell secretory mechanisms (triggered, for instance, by the primary induction of Ca++ fluxes) or be the result of the actual passage of cytosolic polypeptides through the MAC pore.
Other investigators have already documented the fact that the MAC pore allows the passage of macromolecules such as RNAase and inulin. These experiments were performed to characterize the exclusion size and other biophysical characteristics of the MAC pore. Here, we demonstrate that the homologous MAC pore is an exit route for cytosolic proteins devoid of signal peptides.
We propose that the homologous MAC pore is a transient route for the release and/or uptake of autocrine, paracrine, and/or endocrine signals across the plasma membrane, and provides a mechanism for the export of proteins devoid of signal peptides. Our results strongly suggest that the release and the uptake of biologically active macromolecules through the homologous MAC pore should be included among the physiological functions of the complement system in mammals.
MATERIALS AND METHODS
Cell Culture HUVEC were cultured in 199/HBSS containing 20 mM NaCO3, 20 mM HEPES, 2 mM L-glutamine, 20% heat inactivated fetal calf serum (FCS), 50 ,g/ml endothelial growth factor (EGF) (Biomedical Technologies, Inc., Stoughton, MA, U.S.A.) and 100 jig/ml heparin (Sigma Chemical Co., St to reach a final concentration of 150 mM. The ghosts were then stirred 5 min 0°C, re-hemolyzed with 100 ml of LB, and the membranes recovered by centrifugation at 17,000 rpm for 10 min. The membranes were washed three or four times, until the ghosts had a grayish white color (less than 5 % hemoglobin). The ghost pellet was resuspended in 2 ml of cold LB, and enough radioactive polypeptide was added to reach a final concentration of 0.8 Ci/ml. After loading, the ghost suspension was made 150 mM with 3 M KCI, and the ghosts were resealed by incubating for 45 min at 370C. The resealed ghosts were sedimented by centrifugation (27,000 g/10 min at 40C) and washed five times with CWS in the presence of cold bFGF (10 ng/ml) or 0.2% bovine serum albumin (BSA) to remove untrapped markers. After the last wash, the ghost pellet was resuspended in 2 ml of GVB++ containing -0.2%
BSA to a final concentration of ,5 X 108 ghosts/ ml.
C5b6-7 ghosts (5 X 108 ghosts/ml) were prepared by incubating the ghost suspension with 8 units of C5b6 and 5 ,ug/ml of purified C7 for 20 min at 37°C. The ghosts carrying C5b67 were washed once with GVB++ and resuspended to the original volume. MAC formation was carried out by incubating the ghosts at 37°C with 5 ,ug/ml of C8 and 5 ,ug/ml of C9. After incubation, aliquots were centrifuged in a MicroSpin 24 Sorvall (14000 rpm/5 min at 170C) and the supernatants collected to measure 1251 in a y counter (Packard Instruments, Meriden, CT, U.S.A.) and hemoglobin absorbance in an enzyme-linked immunosorbent assay (ELISA) plate reader (414 nm) (Biorad, Hercules, CA, U.S.A.). Release of radioactive markers was determined by counting samples of the supernatant fluids as well as the residual ghost pellets. The amount of marker released was expressed as the percentage of the total radioactivity trapped in the original suspension ghosts after resealing.
Monolamellar Lipid Vesicles Preparation
Vesicles were prepared by mixing Asolectin (60 mg/ml in 150 mM NaCl) with 14C-oleic acid (1.8 ,uCi/ml of vesicles; SA: 0.1 ,uCi/,ll) (DuPont NEN, Boston, MA, U.S.A.) (16) . After vortexing the sample for 1 min, enough radioactive polypeptide ('25I-IL-1) was added to reach a final concentration of 0.8 ,uCi/ml. The mixture was stained with a small amount of Oxanol (Molecular Probes, Eugene, OR, U.S.A.) to label the vesicles and sonicated until the preparation was translucent. In order to obtain unilamellar vesicles, multilamellar vesicles were subjected to 10 freezing and thawing cycles, then passed 10 times through a 0.1-,um polycarbonate filter (Nucleopore Corp., Pleasanton, CA, U.S.A.), and finally inserted into a LiposoFast-Basic (Avestin Inc., Ottawa, Canada).
MAC formation in the vesicles was carried out by incubating the vesicles at 37°C with 8 units of C5b-6, C7, C8, and C9 in a sequence and concentration similar to those described for ghosts. After 30 min, aliquots were collected and centrifuged in an air ultracentrifuge (Beckman Instruments, Palo Alto, CA, U.S.A.) at 60,000 rpm for 30 min. Supernatant was used to measure 125j as an indicator of IL-1 release, and 14C as an indicator of lipid vesicles remaining in the supernatant.
Influx Experiment in Human
Red Blood Cells The influx of labeled polypeptides into human red blood cells in the presence and absence of MAC pore lesions was conducted essentially as described before with minor modifications (17).
Incorporation of 10 kD FITC-Dextran in HUVEC On the second passage HUVEC were grown to confluence in either chamber slides or 1 6-mm dishes (37°C, 5% C02), and exposed sequentially to 100 ,l of C5b6 protein containing 6 hemolytic units and 100 ,lI of C7 (30 ,tg/ml) containing 10-kD fluorescent dextran (10 mg/ml). Three minutes later, 100 ,l of C8-C9 (30 ,ug/ml each) were added. After 15 min of incubation at 370C, the HUVEC were washed four times in Dulbecco's modified Eagle's medium (DMEM) without phenol red -0.1% BSA, fixed with paraformaldehyde 2%, and immediately examined using a fluorescence microscope (Axiophot, Zeiss). Parallel experiments were performed on HUVEC seeded on 24-well plates to determine LDH release under the same conditions (18) . Saponin-treated cells were used as a positive control for cell lysis and release of LDH.
RESULTS
Homologous MAC Insertion Does Not Cause Cell Lysis Previous work has established that HUVEC release bFGF to the culture medium when targeted with purified human terminal complement components which form homologous MAC pores in the cell membrane (13) . One possible explanation for this phenomenon could be that bFGF is released into the conditioned media because a small population of cells undergo colloid-osmotic lysis upon homologous MAC insertion. To exclude this possibility, we analyzed the relationship between cell lysis and bFGF release in homologous MAC-impacted cells. Release of LDH and uptake of trypan blue were measured to estimate the amount of cell lysis produced by homologous MAC (18) . Exposure of the cells to homologous MAC at concentrations that released a significant amount of bFGF neither induced the release of LDH nor the uptake of trypan blue (data not shown). Furthermore, follow-up for up to 48 h after treatment with the homologous MAC failed to detect any significant morphologic differences when MAC-treated and control cells were compared. In contrast, saponin-treated cells released LDH to the supernatant and incorporated trypan blue. These results indicate that release of bFGF from HUVEC is a nonlethal effect of the homologous MAC that occurs without cell lysis.
FITC-Dextran Uptake by HUVEC Impacted with Homologous MAC Permeability of the MAC pore to dextrans of different molecular weights has been described in a heterologous system (sheep red blood cellshuman complement) (19) . To investigate whether the homologous MAC pore at nonlytic concentrations could be a bidirectional pathway for the diffusion of macromolecules across cell membranes, HUVEC were exposed to human terminal complement components in the presence of 10 kD FITC-dextran. The whole population of HUVEC treated with sublytic homologous MAC trapped fluorescent dextran (Fig. 1) . In contrast, no fluorescence was detected in either control cells exposed for the same time interval to a similar concentration of FITC-dextran in the absence of MAC, or in HUVEC exposed to the terminal complement components in a sequence that does not induce formation of the MAC (not shown). These controls ruled out any nonspecific adsorption of the fluorescent compound occurring independently of the homologous MAC formation. No evidence of cell lysis was detected, as measured by the release of LDH. These results indicate that upon MAC formation HUVEC become permeable to 10-kD FITC-dextran. Human red blood cells were exposed to C5b-7 or C5b-9 (0.3 units) in the presence of 1251-IFNy. Uptake of the radiolabeled polypeptide was measured after 30 min. Influx was calculated from the hemoglobin of the sample lysate, the hematocrit of the initial cell suspension, and the specific activity of the tracer in the influx medium. Results are expressed as cpm/l of cells and represent averages of two experiments performed in duplicate. Table 2 shows that the uptake of 125I-a-IFNy into MAC-treated ghosts was 2-fold higher than in control ghosts exposed only to C5b-7. These results confirm that the homologous MAC pore allows for the bidirectional movement of macromolecules.
Release of IL-I from Vesicles After 30 min of exposure to homologous MAC, '4C-oleic acid-labeled vesicles loaded with 1251_ IL-I released five times more peptide than control vesicles (Fig. 6) . No 14C counts were detected in the supernatants after centrifugation at 60,000 rpm for 30 (14) and that homologous MAC insertion into HUVEC induces the release of bFGF and PDGF. These findings together with the recent demonstration that the MAC induces the release of MCP-1 (8 kD) from smooth muscle cells, provide strong evidence for the existence of a functional link between the deposition of terminal complement components and cell proliferation in pathological processes (13,3 1) . The results presented in this article show that (i) upon insertion of the MAC pore, bFGF and IL-I (two polypeptides devoid of signal peptides) as well as the a-chain of IFNy, are released from ghost and lipid vesicles; (ii) the MAC pore restricts by mass, not by molecular shape; and (iii) the MAC pore allows the influx of 10-kD FITCdextran into HUVEC, and a-IFNy into red blood cells, with no evidence of cell lysis.
The diffusion of ions and macromolecules in and out of red blood cells, ghosts, and vesicles through the MAC pore in heterologous systems is a well known phenomenon and has been extensively studied (10, 1 1,20,32-3 5) . Experiments with heterologous systems helped to define the biophysical properties of the pore such as molecular dimensions, sieving characteristics, and permeability, but were not intended to explore whether the MAC (12) . Moreover, ghosts are remarkably nonleaky, and it is precisely this characteristic that makes them useful model systems for biochemical, morphological, and membrane transport studies (15) .
If MAC-induced lysis is excluded as a mechanism of bFGF and IL-1 release from MAC-targeted ghosts, the only alternative to diffusion through the MAC pore itself would be a membrane transporter, which, upon activation by some complement factor, would carry the peptides across the membrane. Since release was only observed in the presence of all terminal complement components added in a sequence that forms the MAC, the putative transporter would be stimulated by insertion of the MAC and be inactive under all other experimental conditions tested in our experiments. This unlikely possibility could explain only the results with ghosts but not those obtained in vesicles because they do not contain any membrane protein that could act as a transporter.
Our results confirm observations published by other authors showing that diffusion of macromolecules through the MAC pore is bidirectional and restricted by their mass. bFGF, IL-1, and a-IFNy are released from ghosts upon the addition of MAC, but IgG is not. Furthermore, we showed that the MAC pore does not restrict by fold, since it allows the passage of bFGF and IL-1, two purely X3 sheet polypeptides, and a-IFNy, a primarily a-helical molecule, devoid of ,B sheets.
The homologous MAC pore may also function as a bidirectional route for macromolecules. We were able to load homologous MAC-impacted HUVEC with 1O-kD FITC-dextran, and homologous MAC-impacted human red blood cells with a-IFNy, without producing cell lysis.
The complement system seems to be ideally suited for facilitating the release of intracellular polypeptides and the uptake of extracellular signals. It is well known that the system is not only activated by immune mechanisms but also by many non-immune conditions and agents, including hypoxia, tissue damage, lipo-polysaccharides, mannan binding protein, C-reactive protein, serum amyloid P components, P3-amyloid peptide, and cholesterol crystal. All of these can trigger the activation of the complement cascade leading to the deposition of C5b-9 (23). The complement proteolytic cascade, as well as the deposition of the homologous MAC pore, are tightly regulated by soluble and membrane regulatory proteins (6) . Insertion of the homologous MAC pore activates the classical ER/G exocytotic mechanism and, as we have shown previously and confirmed here, also creates a pathway for the export of cytosolic proteins lacking conventional signal peptides. Furthermore, the life span of the pore in homologous cells is very short (2 to 7 min) because the insertion of the homologous MAC pore induces cytoskeletal changes that result in the active shedding of pore-enriched membrane segments (36) . This short life span of the MAC pore is totally compatible with our previous results, which have shown release of bFGF from HUVEC within 1 min after MAC insertion. Moreover, proteins without signal peptides tend to be concentrated in the ectocytosol (2) immediately below the plasma membrane. This cellular location would increase the efficient concentration for diffusion and make the proteins readily available for release through the MAC pore. All these characteristics seem to be ideally suited for a localized, transitory, and reversible mechanism of bidirectional transport.
Taken together, the present results strongly support the hypothesis that the homologous MAC pore could be a route for the release and/or uptake of biologically active polypeptides, including those lacking a signal peptide. If this property of the homologous MAC pore occurs in vivo, the opening of transient pores for the transit of biologically active molecules across cell membranes would constitute a novel, previously unsuspected role of the complement system in animal biology.
